Gene therapy in mesotheliomas

Onkologie

Volumn 31, Issue 3, 2008, Pages 82-

  Hengge, Ulrich R ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SURVIVAL; CANCER THERAPY; DNA IMMUNIZATION; EDITORIAL; GENE TECHNOLOGY; GENE THERAPY; MESOTHELIOMA; NONHUMAN; SUICIDE GENE THERAPY;

ANIMALS; GENE THERAPY; GENES, TRANSGENIC, SUICIDE; MESOTHELIOMA; MICE; TRANSDUCTION, GENETIC;

EID: 40449087977     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000117180     Document Type: Editorial

References (6)

1. Veldwijk MR, Berlinghoff S, Jauch A, Laufs S, Zeller WJ, Wenz F, Fruehauf S: Characterization of human mesothelioma cell lines as tumor models for suicide gene therapy. Onkologie 2008;31:91-96.
2. Kane AB: Animal models of malignant mesothelioma. Inhal Toxicol 2006;18:1001-1004.
3. Chang CL, Wu TC, Hung CF: Control of human mesothelin-expressing tumors by DNA vaccines. Gene Ther 2007;14:1189-1198.
4. Adusumilli PS, Stiles BM, Chan MK, Mullerad M, Eisenberg DP, Ben-Porat L, Huq R, Rusch VW, Fong Y: Imaging and therapy of malignant pleural mesothelioma using replication-competent herpes simplex viruses. J Gene Med 2006;8:603-615.
5. van der Most RG, Robinson BW, Nelson DJ: Gene therapy for malignant mesothelioma: beyond the infant years. Cancer Gene Ther 2006;13:897-904.
6. Sterman DH, Recio A, Carroll RG, Gillespie CT, Haas A, Vachani A, Kapoor V, Sun J, Hodinka R, Brown JL, Corbley MJ, Parr M, Ho M, Pastan I, Machuzak M, Benedict W, Zhang XQ, Lord EM, Litzky LA, Heitjan DF, June CH, Kaiser LR, Vonderheide RH, Albelda SM, Kanther M: A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses. Clin Cancer Res 2007;13:4456-4466.